HomeTagsNovo Nordisk to license obesity drug from Lexicon in up to $1 billion deal

Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal
N

Continue reading...

Novo Nordisk to license obesity drug from Lexicon in up to...

Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal Novo Nordisk (NOVOb.CO), opens new tab is licensing Lexicon Pharmaceuticals' (LXRX.O),...

Subscribe for Exclusive Access

All

Exclusive Content

EXCLUSIVEThe Future of Work: Embracing Automation and Reskilling for a Sustainable...

October 25, 2024

All

Exclusive Content

EXCLUSIVEBeyond Profit: Embracing Corporate Social Responsibility for a Better World

October 25, 2024

All

Exclusive Content

EXCLUSIVEThe Power of Art: How Creativity Transforms Perspectives and Ignites Change

October 25, 2024

All

Exclusive Content

EXCLUSIVEThe Power of Recycling: Transforming Waste into Valuable Resources

October 25, 2024

The World of Health & Medicine News

New lasso-shaped antibiotic kills drug-resistant bacteria

Chinese brain chip project speeds up human trials after first success

Experimental drug lepodesiran reduces genetic risk factor for heart disease by 94 percent

Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal

Vykat XR approved for genetic binge eating disorder

Keytruda subcutaneous injection to launch on October 1

Buying an autoimmune disease drug for $1.3 billion

US FDA approves Sanofi’s bleeding disorder therapy

Monjaro weight loss drug hits Indian market

Merck buys exclusive rights to Chinese company’s heart disease drug

Or continue exploring...

Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal
N

Continue reading...

Novo Nordisk to license obesity drug from Lexicon in up to...

Subscribe for Exclusive Access

EXCLUSIVEThe Future of Work: Embracing Automation and Reskilling for a Sustainable...

EXCLUSIVEBeyond Profit: Embracing Corporate Social Responsibility for a Better World

EXCLUSIVEThe Power of Art: How Creativity Transforms Perspectives and Ignites Change

EXCLUSIVEThe Power of Recycling: Transforming Waste into Valuable Resources

The World of Health & Medicine News

Or continue exploring...

Novo Nordisk to license obesity drug from Lexicon in up to $1 billion dealN

Continue reading...

Subscribe for Exclusive Access

.tdi_173{margin-bottom:40px!important} EXCLUSIVEBeyond Profit: Embracing Corporate Social Responsibility for a Better World

.tdi_192{margin-bottom:40px!important} EXCLUSIVEThe Power of Art: How Creativity Transforms Perspectives and Ignites Change

.tdi_211{margin-bottom:40px!important} EXCLUSIVEThe Power of Recycling: Transforming Waste into Valuable Resources

Novo Nordisk to license obesity drug from Lexicon in up to $1 billion deal
N

EXCLUSIVEBeyond Profit: Embracing Corporate Social Responsibility for a Better World

EXCLUSIVEThe Power of Art: How Creativity Transforms Perspectives and Ignites Change

EXCLUSIVEThe Power of Recycling: Transforming Waste into Valuable Resources